Olaparib combined with chemotherapy for treatment of T-cell acute lymphoblastic leukemia relapse after unrelated umbilical cord blood transplantation.

As one of the most common hematological malignancies, T-cell acute lymphoblastic leukemia (T-ALL) accounts for 20–25% of all acute lymphoblastic leukemia cases and is often accompanied by mediastin...